Form 8-K - Current report:
SEC Accession No. 0001104659-15-060095
Filing Date
2015-08-14
Accepted
2015-08-14 16:44:06
Documents
8
Period of Report
2015-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-17643_18k.htm 8-K 33744
2 EX-4.1 a15-17643_1ex4d1.htm EX-4.1 872622
3 GRAPHIC g176431ki15i001.jpg GRAPHIC 1670
4 GRAPHIC g176431ki15i002.jpg GRAPHIC 2057
5 GRAPHIC g176431ki15i003.jpg GRAPHIC 2347
6 GRAPHIC g176431ki15i004.jpg GRAPHIC 2308
7 GRAPHIC g176431ki17i001.jpg GRAPHIC 2000
8 GRAPHIC g176431ki17i002.jpg GRAPHIC 2700
  Complete submission text file 0001104659-15-060095.txt   926684
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 151056604
SIC: 2834 Pharmaceutical Preparations